Bank of New York Mellon’s Axogen AXGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $7.04M | Buy |
152,451
+14,321
| +10% | +$577K | ﹤0.01% | 2232 |
|
|
2026
Q1 | $4.58M | Buy |
138,130
+3,415
| +3% | +$111K | ﹤0.01% | 2366 |
|
|
2025
Q4 | $4.41M | Sell |
134,715
-3,257
| -2% | -$80.1K | ﹤0.01% | 2390 |
|
|
2025
Q3 | $2.46M | Buy |
137,972
+2,735
| +2% | +$39.7K | ﹤0.01% | 2693 |
|
|
2025
Q2 | $1.47M | Buy |
135,237
+7,108
| +6% | +$93.1K | ﹤0.01% | 2899 |
|
|
2025
Q1 | $2.37M | Sell |
128,129
-1,557
| -1% | -$28.1K | ﹤0.01% | 2608 |
|
|
2024
Q4 | $2.14M | Sell |
129,686
-1,764
| -1% | -$25K | ﹤0.01% | 2734 |
|
|
2024
Q3 | $1.84M | Sell |
131,450
-29,442
| -18% | -$326K | ﹤0.01% | 2792 |
|
|
2024
Q2 | $1.16M | Buy |
160,892
+13,798
| +9% | +$94.3K | ﹤0.01% | 3104 |
|
|
2024
Q1 | $1.19M | Sell |
147,094
-8,329
| -5% | -$74.6K | ﹤0.01% | 3056 |
|
|
2023
Q4 | $1.06M | Buy |
155,423
+20,333
| +15% | +$113K | ﹤0.01% | 3155 |
|
|
2023
Q3 | $675K | Buy |
135,090
+266
| +0.2% | +$1.84K | ﹤0.01% | 3398 |
|
|
2023
Q2 | $1.23M | Buy |
134,824
+3,146
| +2% | +$29.3K | ﹤0.01% | 3086 |
|
|
2023
Q1 | $1.24M | Sell |
131,678
-3,763
| -3% | -$34.4K | ﹤0.01% | 3048 |
|
|
2022
Q4 | $1.35M | Sell |
135,441
-1,867
| -1% | -$20.7K | ﹤0.01% | 3049 |
|
|
2022
Q3 | $1.64M | Buy |
137,308
+12,170
| +10% | +$122K | ﹤0.01% | 2958 |
|
|
2022
Q2 | $1.02M | Buy |
125,138
+3,910
| +3% | +$33.4K | ﹤0.01% | 3199 |
|
|
2022
Q1 | $962K | Buy |
121,228
+483
| +0.4% | +$4.17K | ﹤0.01% | 3342 |
|
|
2021
Q4 | $1.13M | Buy |
120,745
+2,609
| +2% | +$31.3K | ﹤0.01% | 3316 |
|
|
2021
Q3 | $1.87M | Buy |
118,136
+7,615
| +7% | +$137K | ﹤0.01% | 3020 |
|
|
2021
Q2 | $2.39M | Sell |
110,521
-22,787
| -17% | -$461K | ﹤0.01% | 2877 |
|
|
2021
Q1 | $2.7M | Sell |
133,308
-6,470
| -5% | -$128K | ﹤0.01% | 2755 |
|
|
2020
Q4 | $2.5M | Sell |
139,778
-3,875
| -3% | -$56.9K | ﹤0.01% | 2709 |
|
|
2020
Q3 | $1.67M | Sell |
143,653
-357,307
| -71% | -$4.15M | ﹤0.01% | 2766 |
|
|
2020
Q2 | $4.63M | Sell |
500,960
-322,094
| -39% | -$2.89M | ﹤0.01% | 2238 |
|
|
2020
Q1 | $8.56M | Sell |
823,054
-52,771
| -6% | -$672K | ﹤0.01% | 1783 |
|
|
2019
Q4 | $15.7M | Sell |
875,825
-121,520
| -12% | -$1.8M | ﹤0.01% | 1713 |
|
|
2019
Q3 | $12.4M | Sell |
997,345
-107,638
| -10% | -$1.77M | ﹤0.01% | 1809 |
|
|
2019
Q2 | $21.9M | Buy |
1,104,983
+27,616
| +3% | +$591K | 0.01% | 1522 |
|
|
2019
Q1 | $22.7M | Sell |
1,077,367
-147,460
| -12% | -$2.69M | 0.01% | 1476 |
|
|
2018
Q4 | $25M | Buy |
1,224,827
+121,856
| +11% | +$3.81M | 0.01% | 1325 |
|
|
2018
Q3 | $40.6M | Buy |
1,102,971
+199,885
| +22% | +$8.73M | 0.01% | 1168 |
|
|
2018
Q2 | $45.4M | Buy |
903,086
+25,748
| +3% | +$1.13M | 0.01% | 1067 |
|
|
2018
Q1 | $32M | Buy |
877,338
+27,345
| +3% | +$839K | 0.01% | 1263 |
|
|
2017
Q4 | $24.1M | Buy |
849,993
+218,430
| +35% | +$5.15M | 0.01% | 1458 |
|
|
2017
Q3 | $12.2M | Buy |
631,563
+471,209
| +294% | +$7.92M | ﹤0.01% | 1886 |
|
|
2017
Q2 | $2.69M | Buy |
160,354
+71,609
| +81% | +$966K | ﹤0.01% | 2669 |
|
|
2017
Q1 | $928K | Sell |
88,745
-575
| -0.6% | -$5.86K | ﹤0.01% | 3285 |
|
|
2016
Q4 | $804K | Buy |
89,320
+7,560
| +9% | +$65.1K | ﹤0.01% | 3378 |
|
|
2016
Q3 | $738K | Buy |
81,760
+1,180
| +1% | +$9.59K | ﹤0.01% | 3338 |
|
|
2016
Q2 | $555K | Buy |
80,580
+53,427
| +197% | +$302K | ﹤0.01% | 3482 |
|
|
2016
Q1 | $146K | Hold |
27,153
| – | – | ﹤0.01% | 3879 |
|
|
2015
Q4 | $136K | Hold |
27,153
| – | – | ﹤0.01% | 3982 |
|
|
2015
Q3 | $112K | Buy |
+27,153
| New | +$109K | ﹤0.01% | 4078 |
|
|
2014
Q1 | – | Sell |
-10,001
| Closed | -$45K | – | 4183 |
|
|
2013
Q4 | $45K | Hold |
10,001
| – | – | ﹤0.01% | 4119 |
|
|
2013
Q3 | $44K | Buy |
+10,001
| New | +$36.7K | ﹤0.01% | 4056 |
|
Other funds holding AXGN
AIM
WA
TCM
CFM
SIMG
Bank of New York Mellon's AXGN Position: Q2 2026 in Review
Bank of New York Mellon increased its Axogen (AXGN) stake by 10% in Q2 2026, buying an estimated $577K and bringing the position to 152,451 shares worth $7.04M. The position accounts for ﹤0.01% of the portfolio, ranked #2232.
Bank of New York Mellon first reported a position in AXGN in Q3 2013 and has held it in 46 quarters since. The position peaked at $45.4M in Q2 2018. 86 funds tracked by Wall St. Rank hold AXGN as of Q2 2026.
- Bank of New York Mellon held 152,451 shares of Axogen worth $7.04M as of Q2 2026.
- Bank of New York Mellon bought 14,321 Axogen shares in Q2 2026, an estimated $577K.
- Axogen made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #2232 holding.
- Bank of New York Mellon first reported a position in Axogen in Q3 2013 and has held it in 46 quarters since.
- Bank of New York Mellon's Axogen position peaked at $45.4M in Q2 2018.
- 86 funds tracked by Wall St. Rank held Axogen as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.